Think

Search This Blog

CureVac’s mRNA vaccine reaches an efficacy level of just 47 percent in a clinical trial.

June 16, 2021

Get link
Facebook
X
Pinterest
Email
Other Apps

BY CARL ZIMMER | NYTimes Health | Disclosure

Get link
Facebook
X
Pinterest
Email
Other Apps

Comments

In Mexico, Heat Waves Are Even Killing Younger Adults

It’s not the just the elderly. More than three-quarters of heat-related deaths in Mexico occurred among people younger than 35, researchers reported. Teddy Rosenbluth | NYTimes Health | Disclosure

How to Talk to Your Teen About Pornography

Odds are your adolescent has already encountered online pornography. Your role is to openly address it, scholars say. Matt Richtel | NYTimes Health | Disclosure

He Built a Wellness Empire While Adventuring With R.F.K. Jr.

Dr. Mark Hyman, a “functional medicine” proponent and longtime friend of Robert F. Kennedy Jr., is finding powerful allies in his bid to treat disease with blood tests and supplements. Brendan Borrell | NYTimes Health | Disclosure

Trump’s Return May Worsen Financial Woes for Global Health Institutions

The U.S. provides nearly half of the aid for global health, including childhood vaccination, H.I.V. treatment and disease surveillance. Stephanie Nolen | NYTimes Health | Disclosure

Alabama Woman Receives Nation’s Third Pig Kidney Transplant

The patient, Towana Looney, was in better health than previous recipients, and her case could signal progress toward solving the organ-supply shortage. Roni Caryn Rabin | NYTimes Health | Disclosure

CureVac’s mRNA vaccine reaches an efficacy level of just 47 percent in a clinical trial.

Comments

Post a Comment